These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 647189)

  • 61. Ascorbate-enhanced cytotoxicity of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Nature; 1978 Jan; 271(5643):370-2. PubMed ID: 622177
    [No Abstract]   [Full Text] [Related]  

  • 62. The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations.
    Saunders MI; Anderson PJ; Bennett MH; Dische S; Minchinton A; Stratford MR; Tothill M
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1759-63. PubMed ID: 6480459
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.
    Liew LP; Shome A; Wong WW; Hong CR; Hicks KO; Jamieson SMF; Hay MP
    Molecules; 2023 May; 28(11):. PubMed ID: 37298933
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiosensitizers.
    Hellmann K
    Antibiot Chemother (1971); 1978; 23():58-63. PubMed ID: 646329
    [No Abstract]   [Full Text] [Related]  

  • 65. The in vitro interaction with DNA of several hypoxic radiosensitizers.
    Santos Peinado L; Cornago Ramirez P; Lopez Zumel C
    Chem Biol Interact; 1989; 71(2-3):245-53. PubMed ID: 2598300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiation sensitizers.
    Cancer; 1976 Apr; 37(4 Suppl):2062-70. PubMed ID: 130967
    [No Abstract]   [Full Text] [Related]  

  • 67. The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study.
    Saunders MI; Dische S; Fermont D; Bishop A; Lenox-Smith I; Allen JG; Malcolm SL
    Br J Cancer; 1982 Nov; 46(5):706-10. PubMed ID: 7171452
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography.
    Workman P; Little CJ; Marten TR; Dale AD; Ruane RJ; Flockhart IR; Bleehen NM
    J Chromatogr; 1978 May; 145(3):507-12. PubMed ID: 659541
    [No Abstract]   [Full Text] [Related]  

  • 69. The effect of the electron affinic sensitizers Ro 07-0582 and Ro 03-6156 on the survival of several E. coli mutants.
    Fielden EM; Sapora O; Loverock PS
    Int J Radiat Biol Relat Stud Phys Chem Med; 1978 Jan; 33(1):41-5. PubMed ID: 342430
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypoxic-cell sensitisers.
    Karim AB
    Lancet; 1978 Oct; 2(8095):891-2. PubMed ID: 81431
    [No Abstract]   [Full Text] [Related]  

  • 71. Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptake.
    Skarsgard LD; Acheson DK; Vinczan A; Wouters BG; Heinrichs BE; Loblaw DA; Minchinton AI; Chaplin DJ
    Br J Cancer; 1995 Dec; 72(6):1479-86. PubMed ID: 8519663
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proceedings: The development of hypoxic cell sensitizers.
    Fielden EM
    Br J Radiol; 1975 Jan; 48(565):74. PubMed ID: 1089025
    [No Abstract]   [Full Text] [Related]  

  • 73. Preferential sensitization of hypoxic cells to radiation in vivo.
    Denekamp J; Michael BD
    Nat New Biol; 1972 Sep; 239(88):21-3. PubMed ID: 4507330
    [No Abstract]   [Full Text] [Related]  

  • 74. Development of radiosensitizers: a medicinal chemistry perspective.
    Narayanan VL; Lee WW
    Adv Pharmacol Chemother; 1982; 19():155-205. PubMed ID: 6762070
    [No Abstract]   [Full Text] [Related]  

  • 75. Hypoxic cell sensitisers in radiotherapy.
    Dische S
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):157-60. PubMed ID: 632144
    [No Abstract]   [Full Text] [Related]  

  • 76. Pharmacology and clinical investigation of SR-2508 (etanidazole).
    O'Dwyer PJ; LaCreta FP
    Cancer Treat Res; 1991; 58():45-63. PubMed ID: 1683785
    [No Abstract]   [Full Text] [Related]  

  • 77. Hypoxia-mediated drugs for radiation and chemotherapy.
    Adams GE
    Cancer; 1981 Aug; 48(3):696-707. PubMed ID: 7018662
    [No Abstract]   [Full Text] [Related]  

  • 78. Radiation therapy and chemotherapy.
    Cancer; 1976 Apr; 37(4 Suppl):2093-107. PubMed ID: 769944
    [No Abstract]   [Full Text] [Related]  

  • 79. Reduction of nitroimidazoles in model chemical and biological systems.
    Wardman P; Anderson RF; Clarke ED; Jones NR; Minchinton AI; Patel KB; Stratford MR; Watts ME
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):777-80. PubMed ID: 7050044
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proceedings: Sensitization of the hypoxic mouse intestine.
    Hornsey S; Hedges MJ
    Br J Radiol; 1975 Jan; 48(565):77. PubMed ID: 1109650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.